Delivery bottlenecks for important medicines: “Situation very tense”. For 85 percent of the urgently needed medicines, the pharmaceutical trade can meet the statutory requirement of two weeks don't make sure.
The pharmaceutical industry accuses: ‘Politicians are just putting small plasters on the problems’ The drugs affected are mainly generics. They are copycat products that are based on already established medications. The problem according to Pro Generika: There are too few manufacturers. There is only one large producer on the market for the breast cancer drug Tamoxifen.